Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$47.99 - $60.21 $537,296 - $674,111
-11,196 Reduced 4.95%
214,983 $10.9 Million
Q1 2023

May 17, 2023

BUY
$52.6 - $67.34 $254,689 - $326,060
4,842 Added 2.19%
226,179 $12.3 Million
Q4 2022

Feb 08, 2023

SELL
$59.56 - $76.6 $13.1 Million - $16.8 Million
-219,730 Reduced 49.82%
221,337 $13.8 Million
Q3 2022

Nov 14, 2022

SELL
$57.96 - $78.12 $1.29 Million - $1.74 Million
-22,238 Reduced 4.8%
441,067 $31.1 Million
Q2 2022

Aug 16, 2022

SELL
$39.5 - $64.42 $290,325 - $473,487
-7,350 Reduced 1.56%
463,305 $26.3 Million
Q1 2022

May 13, 2022

SELL
$43.74 - $62.76 $20,995 - $30,124
-480 Reduced 0.1%
470,655 $29.5 Million
Q4 2021

Feb 16, 2022

BUY
$50.01 - $73.35 $4 Million - $5.87 Million
80,068 Added 20.47%
471,135 $26.4 Million
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $666,053 - $884,846
11,249 Added 2.96%
391,067 $25.5 Million
Q2 2021

Aug 19, 2021

BUY
$51.39 - $66.9 $2.02 Million - $2.63 Million
39,321 Added 11.55%
379,818 $24.1 Million
Q1 2021

May 17, 2021

BUY
$49.14 - $59.89 $1.17 Million - $1.42 Million
23,728 Added 7.49%
340,497 $20.4 Million
Q4 2020

Feb 16, 2021

BUY
$42.19 - $51.5 $1.43 Million - $1.75 Million
33,979 Added 12.02%
316,769 $15.8 Million
Q3 2020

Nov 10, 2020

SELL
$35.33 - $51.04 $2.73 Million - $3.95 Million
-77,388 Reduced 21.49%
282,790 $14.4 Million
Q2 2020

Aug 12, 2020

SELL
$22.91 - $39.83 $2.94 Million - $5.12 Million
-128,483 Reduced 26.29%
360,178 $12.6 Million
Q1 2020

May 15, 2020

BUY
$16.44 - $37.73 $21,963 - $50,407
1,336 Added 0.27%
488,661 $12.4 Million
Q4 2019

Feb 13, 2020

BUY
$19.57 - $28.96 $5.67 Million - $8.38 Million
289,495 Added 146.34%
487,325 $13.5 Million
Q3 2019

Nov 14, 2019

BUY
$26.92 - $42.41 $5.33 Million - $8.39 Million
197,830 New
197,830 $5.33 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.